These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 11341503

  • 1. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
    Van Thiel DH, George M, Fareed J.
    Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503
    [Abstract] [Full Text] [Related]

  • 2. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P.
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [Abstract] [Full Text] [Related]

  • 3. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
    Chen CC, Lee KD, Gau JP, Yu YB, You JY, Lee SC, Hsu HC, Chau WK, Ho CH.
    Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
    [Abstract] [Full Text] [Related]

  • 4. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
    Ermantas N, Guldiken S, Demir M, Tugrul A.
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):568-73. PubMed ID: 19959491
    [Abstract] [Full Text] [Related]

  • 5. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
    Hayakawa M, Sawamura A, Gando S, Jesmin S, Naito S, Ieko M.
    Thromb Res; 2012 Dec; 130(6):906-13. PubMed ID: 22353215
    [Abstract] [Full Text] [Related]

  • 6. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T, Gando S, Mizugaki A, Yanagida Y, Jesmin S, Yokota H, Ieko M.
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [Abstract] [Full Text] [Related]

  • 7. TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survival.
    Gresele P, Binetti BM, Branca G, Clerici C, Asciutti S, Morelli A, Semeraro N, Colucci M.
    Thromb Res; 2008 Jul; 121(6):763-8. PubMed ID: 17915296
    [Abstract] [Full Text] [Related]

  • 8. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis EA.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [Abstract] [Full Text] [Related]

  • 9. Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever.
    Sonmez M, Aydin K, Durmus A, Sucu N, Yilmaz M, Akdogan E, Koksal I, Ovali E, Omay SB.
    J Infect; 2007 Aug; 55(2):184-7. PubMed ID: 17418898
    [Abstract] [Full Text] [Related]

  • 10. TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit.
    Paola Cellai A, Antonucci E, Alessandrello Liotta A, Fedi S, Marcucci R, Falciani M, Giglioli C, Abbate R, Prisco D.
    Thromb Res; 2006 Aug; 118(4):495-500. PubMed ID: 16318869
    [Abstract] [Full Text] [Related]

  • 11. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [Abstract] [Full Text] [Related]

  • 12. Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases.
    Saibeni S, Bottasso B, Spina L, Bajetta M, Danese S, Gasbarrini A, de Franchis R, Vecchi M.
    Am J Gastroenterol; 2004 Oct; 99(10):1966-70. PubMed ID: 15447757
    [Abstract] [Full Text] [Related]

  • 13. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.
    Francis RB, Seyfert U.
    J Lab Clin Med; 1987 Nov; 110(5):541-7. PubMed ID: 3117952
    [Abstract] [Full Text] [Related]

  • 14. Thrombin activatable fibrinolysis inhibitor (TAFI): relationship to hemostatic alteration in patients with beta-thalassemia.
    Mokhtar GM, Matter RM, Shawki H, Abdel Aziz MM.
    Pediatr Hematol Oncol; 2010 Aug; 27(5):363-73. PubMed ID: 20670166
    [Abstract] [Full Text] [Related]

  • 15. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
    Cruden NL, Graham C, Harding SA, Ludlam CA, Fox KA, Newby DE.
    Thromb Res; 2006 Aug; 118(2):189-97. PubMed ID: 16055173
    [Abstract] [Full Text] [Related]

  • 16. Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients.
    Malyszko J, Malyszko JS, Hryszko T, Mysliwiec M.
    Transplant Proc; 2006 Aug; 38(1):105-7. PubMed ID: 16504676
    [Abstract] [Full Text] [Related]

  • 17. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J, Hudecek J, Kubisz P.
    Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
    [Abstract] [Full Text] [Related]

  • 18. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 19. Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis.
    Ricart JM, Ramón LA, Vayá A, España F, Santaolaria ML, Todolí J, Castelló R, Fontcuberta J, Estellés A.
    Br J Haematol; 2008 May; 141(5):716-9. PubMed ID: 18341631
    [Abstract] [Full Text] [Related]

  • 20. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE.
    Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.